Hummer Financial Advisory Services’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$287K Hold
1,410
0.19% 99
2026
Q1
$265K Buy
1,410
+50
+4% +$9.63K 0.19% 101
2025
Q4
$257K Sell
1,360
-50
-4% -$9.25K 0.18% 100
2025
Q3
$234K Hold
1,410
0.17% 110
2025
Q2
$216K Hold
1,410
0.16% 109
2025
Q1
$222K Hold
1,410
0.18% 100
2024
Q4
$221K Hold
1,410
0.18% 102
2024
Q3
$250K Hold
1,410
0.2% 92
2024
Q2
$237K Hold
1,410
0.21% 94
2024
Q1
$235K Hold
1,410
0.19% 95
2023
Q4
$233K Hold
1,410
0.21% 89
2023
Q3
$220K Hold
1,410
0.22% 90
2023
Q2
$220K Buy
+1,410
New +$225K 0.22% 90
2023
Q1
Sell
-1,360
Closed -$217K 85
2022
Q4
$217K Buy
+1,360
New +$215K 0.24% 87
2022
Q3
Sell
-1,410
Closed -$206K 87
2022
Q2
$206K Hold
1,410
0.23% 92
2022
Q1
$229K Buy
1,410
+200
+17% +$32.4K 0.21% 94
2021
Q4
$229K Sell
1,210
-200
-14% -$38.6K 0.19% 93
2021
Q3
$285K Hold
1,410
0.26% 84
2021
Q2
$284K Hold
1,410
0.26% 83
2021
Q1
$247K Hold
1,410
0.24% 89
2020
Q4
$239K Hold
1,410
0.25% 87
2020
Q3
$229K Hold
1,410
0.27% 82
2020
Q2
$230K Buy
+1,410
New +$214K 0.29% 78

Other funds holding BBH

Hummer Financial Advisory Services's BBH Position: Q2 2026 in Review

Hummer Financial Advisory Services held its VanEck Biotech ETF (BBH) position steady in Q2 2026 at 1,410 shares worth $287K. The position accounts for 0.19% of the portfolio, ranked #99.

Hummer Financial Advisory Services first reported a position in BBH in Q2 2020 and has held it in 23 quarters since. 35 funds tracked by Wall St. Rank hold BBH as of Q2 2026.

  • Hummer Financial Advisory Services held 1,410 shares of VanEck Biotech ETF worth $287K as of Q2 2026.
  • Hummer Financial Advisory Services left its VanEck Biotech ETF share count unchanged in Q2 2026.
  • VanEck Biotech ETF made up 0.19% of Hummer Financial Advisory Services's portfolio in Q2 2026, its #99 holding.
  • Hummer Financial Advisory Services first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 23 quarters since.
  • 35 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q2 2026.

Based on Hummer Financial Advisory Services's 13F filing for Q2 2026, filed 7 Jul 2026.